首页 | 本学科首页   官方微博 | 高级检索  
     


The value of serum pro-oxidant/antioxidant balance in the assessment of asphyxia in term neonates
Authors:Hassan Boskabadi  Mohammad Heidarzadeh  Amir Avan  Majid Ghayour-Mobarhan  Gordon A. Ferns
Affiliation:1. Department of Pediatrics, Neonatal Research Center, Ghaem Hospital, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran,;2. Department of Pediatrics, Community Medicine and Public Health, Tabriz University of Medical Sciences, Tabriz, Iran,;3. Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran,;4. Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, and;5. Division of Medical Education, Brighton and Sussex Medical School, Brighton, UK
Abstract:
Objective: Asphyxia is a major cause of disabilities in term-born infants. Here we have explored the value in HIE (hypoxic-ischemic-encephalopathy) of using a combination of serum pro-oxidant/antioxidant balance (PAB) assay for predicting the prognosis of asphyxia.

Method: Ninety term neonates with asphyxia were enrolled and followed up for two years. Serum PAB, demographic/biochemical characteristics of mothers, and their neonates were determined. The Denver II test was used to assess outcomes.

Results: Of the 90 asphyxiated neonates, 47 (52.2%) had a normal outcome and 43 babies (47.8%) had abnormal outcome. Serum PAB levels in neonates with normal and abnormal outcomes were 17.1?±?9.23 and 48.27?±?41.30 HK, respectively. A combination of HIE intensity and PAB, compared to other indicators, had a higher predictive-value (95.2%) for outcomes in asphyxiated babies.

Conclusion: We demonstrate that PAB in combination with HIE grade may have a better predictive value for the prognosis of asphyxiated babies and predicting future neurologic problems in asphyxiated term infants.
Keywords:Asphyxia  hypoxic ischemic encephalopathy  newborn  PAB balance
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号